CorMedix, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US21900C3088
USD
10.64
0.86 (8.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
39.74
39.08
31.21
11.46
0.81
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
39.74
39.08
31.21
11.46
0.81
0.00
0.00
Raw Material Cost
1.86
1.60
1.18
0.69
0.51
0.82
0.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.01
0.01
0.01
0.01
0.00
Selling and Distribution Expenses
15.89
14.17
15.37
13.33
14.95
15.05
13.33
Other Expenses
0.24
0.32
0.17
0.07
0.06
0.08
0.23
Total Expenditure (Excl Depreciation)
20.19
18.96
18.27
14.74
16.11
16.70
15.67
Operating Profit (PBDIT) excl Other Income
19.5
20.099999999999998
12.9
-3.3000000000000003
-15.3
-16.7
-15.700000000000001
Other Income
0.81
0.53
0.54
0.52
1.16
0.85
0.91
Operating Profit (PBDIT)
20.52
20.82
13.65
-2.65
-14.03
-15.79
-14.70
Interest
0.01
0.01
0.01
0.01
0.01
0.01
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
37.87
37.48
30.03
10.77
0.30
-0.82
-0.05
Depreciation
0.16
0.16
0.17
0.11
0.11
0.06
0.05
Profit Before Tax
20.35
20.64
13.46
-2.78
-14.15
-15.86
-14.75
Tax
0.52
0.00
0.00
0.00
0.00
-1.39
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.83
20.64
13.46
-2.78
-14.15
-14.47
-14.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.83
20.64
13.46
-2.78
-14.15
-14.47
-14.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.83
20.64
13.46
-2.78
-14.15
-14.47
-14.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
220.63
114.89
84.66
58.71
46.18
58.01
70.14
Earnings per share (EPS)
0.28
0.3
0.22
-0.05
-0.25
-0.25
-0.26
Diluted Earnings per share
0.28
0.3
0.22
-0.05
-0.25
-0.25
-0.26
Operating Profit Margin (Excl OI)
49.18%
51.5%
41.45%
-28.7%
-1898.09%
0.0%
0.0%
Gross Profit Margin
51.62%
53.24%
43.69%
-23.24%
-1741.45%
0.0%
0.0%
PAT Margin
49.9%
52.82%
43.14%
-24.24%
-1755.51%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.53% vs 25.32% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -3.88% vs 52.59% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -2.96% vs 54.96% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of CorMedix, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
39.74
0.00
39.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
39.74
0.00
39.74
Raw Material Cost
1.86
0.00
1.86
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.12
-0.12
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
15.89
0.80
15.09
1,886.25%
Other Expenses
0.24
-0.01
0.25
2,500.00%
Total Expenditure (Excl Depreciation)
20.19
0.79
19.40
2,455.70%
Operating Profit (PBDIT) excl Other Income
19.54
-0.79
20.33
2,573.42%
Other Income
0.81
0.18
0.63
350.00%
Operating Profit (PBDIT)
20.52
-0.60
21.12
3,520.00%
Interest
0.01
0.00
0.01
Exceptional Items
0.00
0.08
-0.08
-100.00%
Gross Profit (PBDT)
37.87
0.00
37.87
Depreciation
0.16
0.00
0.16
Profit Before Tax
20.35
-0.53
20.88
3,939.62%
Tax
0.52
0.00
0.52
Provisions and contingencies
0
0
0.00
Profit After Tax
19.83
-0.53
20.36
3,841.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.83
-0.53
20.36
3,841.51%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.83
-0.53
20.36
3,841.51%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
220.63
12.59
208.04
1,652.42%
Earnings per share (EPS)
0.28
-0.04
0.32
800.00%
Diluted Earnings per share
0.28
-0.04
0.32
800.00%
Operating Profit Margin (Excl OI)
49.18%
0.00%
0.00
49.18%
Gross Profit Margin
51.62%
0.00%
0.00
51.62%
PAT Margin
49.90%
0.00%
0.00
49.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3.97 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.53% vs 25.32% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4,862.50% vs 0.00% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.98 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.88% vs 52.59% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 239.44% vs -25.66% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.97 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.96% vs 54.96% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 229.61% vs -28.81% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 49.18%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024